ClinicalTrials.gov record
Terminated No phase listed Observational

STRIDE Study - A Study in Subjects With LOPD Who Are Currently Being Treated With ERT

ClinicalTrials.gov ID: NCT03347253

Public ClinicalTrials.gov record NCT03347253. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 1:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective Study in Subjects With Late Onset Pompe Disease Who Are Currently Being Treated With Enzyme Replacement Therapy

Study identification

NCT ID
NCT03347253
Recruitment status
Terminated
Study type
Observational
Phase
Not listed
Lead sponsor
Amicus Therapeutics
Industry
Enrollment
12 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 7, 2017
Primary completion
Nov 29, 2018
Completion
Nov 29, 2018
Last update posted
Jul 7, 2025

2017 – 2018

United States locations

U.S. sites
17
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
University of California, Irvine Irvine California 92868
University of Florida Clinical Research Center Gainesville Florida 32611
Emory University Decatur Georgia 30033
University of Kansas Medical Center Kansas City Kansas 66160
Baystate Medical Center Springfield Massachusetts 01199
University of Minnesota Medical Center Minneapolis Minnesota 55455
Hackensack University Medical Center Hackensack New Jersey 07601
Jacobs & Levy Genomic Medicine and Research Program Morristown New Jersey 07960
Northwell Health Great Neck New York 11021
NYU Neurogenetics New York New York 10016
Duke University Medical Center Durham North Carolina 27710
Cincinnati Children's Hospital Cincinnati Ohio 45229
Ohio State University Columbus Ohio 43210
Oregon Health& Science University Portland Oregon 97239
Penn State Hershey Medical Center Hershey Pennsylvania 17033
University of Pittsburgh Pittsburgh Pennsylvania 15261
The University of Texas Health Science Center San Antonio San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03347253, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 7, 2025 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03347253 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →